Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA.
Different tissues or body fluids in which human immunodeficiency virus type 1 (HIV-1) can reside may contain viruses with distinct characteristics. Sixteen HIV-1-infected patients receiving zidovudine or didanosine were studied cross-sectionally and 1 patient who switched from zidovudine to didanosine was followed sequentially to determine if drug resistance mutations within the HIV-1 pol gene at codons 74 and 215 differed depending on the compartment from which the gene was isolated (plasma, seminal fluid, peripheral blood mononuclear cells, or seminal nonspermatozoal mononuclear cells). Cell-free virus in plasma and semen developed detectable mutations first, followed by proviral DNA in seminal nonspermatozoal and peripheral blood mononuclear cells. Study of the appearance of HIV-1 mutations in various compartments may help elucidate how the populations and dynamics of the virus differ throughout the body and determine whether seminal cell-free virus or provirus is the major sexually transmitted form.
Center for AIDS Research, Stanford University Medical Center, California 94305.
K L
KL
Kroodsma
M J
MJ
Kozal
K A
KA
Hamed
M A
MA
Winters
T C
TC
Merigan
D003430:Cross-Sectional Studies; D004279:DNA, Viral / Q000032:analysis*; D004351:Drug Resistance / Q000235:genetics; D005814:Genes, Viral; D015751:Genes, pol; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation; D011533:Proviruses / Q000235:genetics*; D012367:RNA, Viral / Q000032:analysis*; D012661:Semen / Q000821:virology*
D004279:DNA, Viral; D012367:RNA, Viral